Edgen에서 BDX 배당금 데이터를 탐색해 보세요. 포트폴리오 계획을 위한 Becton Dickinson and Co의 배당금 및 주가 추세에 대한 인공지능 기반 통찰력.



재무사항

BDX 재무

Becton Dickinson and Co

$149.52

-0.46%

$-0.69

종가: Apr 28, 16:00:00 GMT-4

$149.52

프리마켓: Apr 29, 06:18:10 GMT-4

개요 예보 수입 배당금 재무사항

주요 통계

이전 종가

$150.22

시가

$151.02

일일 범위

$147.85 - $151.85

52주 범위

$127.58 - $187.35

거래량

2.0M

평균 거래량

2.8M

배당수익률

2.70%

EPS(TTM)

6.12

시가총액

$42.5B

BDX란 무엇인가요?

Becton, Dickinson & Co. is a global medical technology company, which engages in the development, manufacture, and sale of medical supplies, devices, laboratory equipment, and diagnostic products. The company is headquartered in Franklin Lakes, New Jersey and currently employs 72,000 full-time employees. The firm is engaged in the development, manufacture and sale of a broad range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, clinical laboratories, and more. The company operates through four segments: BD Medical Essentials, BD Connected Care, BD BioPharma Systems and BD Interventional. BD Medical Essentials segment includes medication delivery solutions and specimen management. BD Connected Care segment includes medication management solutions and advanced patient monitoring. BD Interventional segment includes urology and critical care, peripheral intervention and surgery.

수입

자산 및 부채 명세서

현금 흐름

연간

분기별

BDX 소득

미화 수백만 달러. 회계 연도는 2월부터 1월까지입니다.

Breakdown	TTM	12/31/2025	09/30/2025	06/30/2025	03/31/2025	12/31/2024
매출	21,924	5,252	5,891	5,509	5,272	5,168
매출 성장률 (YoY)	6%	2%	8%	10%	5%	10%
매출원가	11,747	2,841	3,092	2,875	2,939	2,933
매출총이익	10,177	2,411	2,799	2,634	2,333	2,235
판매비와관리비	5,352	1,393	1,366	1,320	1,273	1,318
연구개발 비용	1,227	306	322	297	302	343
영업비용	6,593	1,710	1,684	1,620	1,579	1,690
기타 비영업 수익(비용)	-102	-10	-23	-32	-37	-15
세전수익(EBT)	1,969	393	510	703	363	306
법인세비용	212	11	17	129	55	3
순이익	1,757	382	493	574	308	303
순이익 성장률	1%	26%	17%	18%	-43%	8%
발행주(희석)	285.84	285.84	287.95	287.22	287.73	290.38
주식 변화 (YoY)	-2%	-2%	-1%	-1%	-1%	0%
EPS (희석주당이익)	6.14	1.33	1.71	1.99	1.07	1.04
EPS 성장률	2%	28%	18%	19%	-42%	9%
잉여현금흐름	2,631	549	1,002	1,045	35	588
주당 잉여현금흐름	--	--	--	--	--	--
매출총이익률	46.41%	45.9%	47.51%	47.81%	44.25%	43.24%
영업이익률	16.34%	13.34%	18.92%	18.4%	14.3%	10.54%
이익률	8.01%	7.27%	8.36%	10.41%	5.84%	5.86%
잉여현금흐름마진	12%	10.45%	17%	18.96%	0.66%	11.37%
EBITDA	6,053	1,315	1,744	1,632	1,362	1,152
EBITDA 마진	27.6%	25.03%	29.6%	29.62%	25.83%	22.29%
D&A for EBITDA	2,469	614	629	618	608	607
EBIT	3,584	701	1,115	1,014	754	545
EBIT 마진	16.34%	13.34%	18.92%	18.4%	14.3%	10.54%
실질 세율	10.76%	2.79%	3.33%	18.34%	15.15%	0.98%

Follow-Up Questions

¿Cuáles son los estados financieros clave de Becton Dickinson and Co?



Según el último estado financiero (Form-10K), Becton Dickinson and Co tiene un total de activos de $0, una ganancia neta 손실 de $0

¿Cuáles son los ratios financieros clave para BDX?



El ratio corriente de Becton Dickinson and Co es 0, el margen neto es 0, las ventas por acción son $0.

¿Cómo se desglosan los ingresos de Becton Dickinson and Co por segmento o geografía?



Becton Dickinson and Co 주요 수익원은 Medication Delivery Solutions이며, 최신 수익 발표에서 수익은 4,575,000,000입니다. 지역별로는 United States이 Becton Dickinson and Co의 주요 시장이며, 수익은 12,790,000,000입니다.

¿Es rentable Becton Dickinson and Co?



no, según los últimos estados financieros, Becton Dickinson and Co tiene una ganancia neta 손실 de $0

¿Tiene Becton Dickinson and Co alguna deuda?



no, Becton Dickinson and Co tiene una deuda de 0

¿Cuántas acciones en circulación tiene Becton Dickinson and Co?



Becton Dickinson and Co tiene un total de acciones en circulación de 0

Becton Dickinson and Co (BDX) 재무

BDX 주가 차트